Weight Loss Diet And Exercise: May 11, 2013

Saturday, May 11, 2013

Katy Perry watches a hockey match in LA

Browse through Glamour's extensive daily celebrity photo gallery online today. Check out what your favourite celebrity has been up to!

View the original article here

Expert Reviews: Timothy Ferriss’s 4-Hour Body

Lose 20 pounds of fat in 30 days (without exercise)? Achieve a 15-minute orgasm?

All this and more is not just possible, it’s probable, says Tim Ferriss, author of the best-selling book, 4-Hour Body: An Uncommon Guide to Rapid Fat-Loss, Incredible Sex, and Becoming Superhuman.

cottage cheese

In his book, Ferriss covers diet, sleep (suggesting six 20-minute naps a day as opposed to 8 straight hours of sleep), exercise, sex, and the perks of medical tourism or undergoing tests or treatment outside the U.S.

Is there any scientific evidence to support some of the outlandish, outrageous claims in Ferriss’s 500-plus page book?

Tim Ferriss is not a doctor, nutritionist, or scientist. He is a 33-year-old author and blogger. He has served as his own guinea pig since high school to develop the program he details in his new book. He did run many of his ideas by a panel of experts, including athletes and scientists, and urges people to see their doctor before following any of his advice.

The book's premise is simple: Less is more, and small, simple changes produce long-lasting effects. “There is zero room for misunderstanding and visible results compel you to continue,” Ferriss writes in his book. “If results are fast and measurable, self-discipline isn't needed.”

How fast and measurable? How about 20 pounds in 30 days without exercise? Ferriss’s "slow-carb" diet promises just that.

The rules are simple (and likely familiar to anyone who has tried a low-carb diet): Avoid white bread, white rice, potatoes, and other white carbs.

Ferriss also says no to whole grains and steel-cut oats, which are often touted as healthy carbs due to their high fiber content. His rapid weight loss plan outlaws all fruit and dairy (except cottage cheese) and involves one “all-you-can-eat day” each week. Cottage cheese speeds fat loss, unlike other dairy products, which slow it, Ferriss writes.

Ferriss suggests eating the same small meals over and over and over again.

He cautions against drinking your calories but allows two glasses of red wine each night (preferably a dry Pinot Noir, Cabernet Sauvignon, or Merlot). “Red wine is by no means required for this diet to work, but it’s 100% allowed (unlike white wines and beer, both which should be avoided),” he writes.

Does this diet make sense?

“The whole notion of avoiding white carbs that turn quickly into sugar is a good thing to do,” says James P. Nicolai, MD, medical director of the Andrew Weil, M.D. Integrative Wellness Program at Miraval Arizona Resort & Spa in Tucson, Ariz.

Also, “it can be helpful to eat the same meals each day because you don’t think about food, as opposed to ‘I am really hungry and don’t have food to eat,” Nicolai says. The latter can set you up for making unhealthy food choices.

View the original article here

Taylor Swift rehearses for her tour

Browse through Glamour's extensive daily celebrity photo gallery online today. Check out what your favourite celebrity has been up to!

View the original article here

Katie Holmes and Suri Cruise in New York

Katie and her ex-husband Tom Cruise are thought to have increased security for their daughter - Get the latest in celebrity style and fashion from Glamour.com. Visit Glamour.com to get all the latest celebrity styles, fashion and gossip.

View the original article here

Drug May Ease Angina in People With Type 2 Diabetes

Ranexa shows effectiveness, especially in patients with poor blood sugar control, study finds

By Robert Preidt

HealthDay Reporter

SUNDAY, March 10 (HealthDay News) -- The drug Ranexa (ranolazine) may help reduce chest pain in people with type 2 diabetes, a new study finds.

The drug is approved in the United States for treatment of chronic angina (chest pain), but this is the first study to evaluate it in patients with diabetes, heart disease and angina, according to the researchers.

One expert not connected to the study said the findings are welcome news for patients.

The study "demonstrates that ranolazine is very effective in reducing angina in those with type 2 diabetes and, interestingly, is more effective in those with higher blood sugars," said Dr. Howard Weintraub, clinical associate professor in the department of medicine at NYU Langone Medical Center in New York City.

People with diabetes are at increased risk for heart disease, and people with heart disease and diabetes are more likely to have angina than those without diabetes, the researchers noted.

The study included more than 900 patients who received either 1,000 milligrams of Ranexa or an inactive placebo twice a day for eight weeks. The patients had type 2 diabetes, heart disease and at least one angina episode a week, and were already taking one or two other anti-angina drugs.

Between weeks two and eight of the study, patients taking Ranexa had an average of 3.8 angina episodes per week, compared with 4.3 episodes per week for those taking the placebo. Patients taking the drug used 1.7 doses of nitroglycerin per week, compared with 2.1 doses per week among those in the placebo group. Nitroglycerin is commonly used to treat or prevent episodes of chest pain in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart).

The study was scheduled for presentation Sunday at the annual meeting of the American College of Cardiology in San Francisco. It was also published online the same day in the Journal of the American College of Cardiology and will appear in the journal's May 21 print issue.

The study was funded by Gilead Sciences, Inc., which makes Ranexa.

"Angina is associated with worse quality of life, increased risk of hospitalization and higher health care costs, and appears to be more prevalent in patients with diabetes," study lead author Dr. Mikhail Kosiborod, associate professor of medicine at the University of Missouri, Kansas City, and a cardiologist at St. Luke's Mid America Heart Institute, said in a meeting news release.

"While ranolazine was shown to be effective in reducing angina in prior studies, this is the first time it has been prospectively evaluated in patients with diabetes -- a high-risk and therapeutically challenging group," he added.

View the original article here

Hayden Panettiere at Palyfest 2013 in LA

Blake Lively wears an oxblood dress by Marios Schwab at The Croods premiere in LA - vote on celebrity fashion, style and red carpet looks in GLAMOUR.COM’s Dos and Don’ts

View the original article here